Push-on-skin activation
Ergonomic, user-friendly design
Molly 2.25 is a large-volume variant of the Molly autoinjector, developed to support the delivery of larger-volume biologics with the same 2-step operation.
Molly at 10: Molly's next chapter
As Molly celebrates 10 years as a commercialized platform, Molly continues to evolve through advances in sustainability, global expansion, and platform performance.
Molly and MIDBA
Molly is well positioned within the EMA's MIDBA framework, helping accelerate eligible monoclonal antibody development programs and bring therapies to market faster.
Read More
Read More
Molly 2.25 is built on a modular platform designed to support a broader range of formulation and self-injection requirements.
Molly 2.25 is on track to be the first 2.25 mL autoinjector with an 8 mm needle pre-filled syringe (PFS) on the market.
Through collaboration with Alliance partners, Molly 2.25 can be configured with an 8 mm needle PFS to support the injection of higher viscosity formulations (up to 50 cP) in under 20 seconds.
SHL Medical is working with customers on projects using 8 mm needle PFS and is on track to be the first to market with a handheld 2.25 mL autoinjector compatible with this format.
Explore how Molly 2.25 can help advance your drug delivery program with a proven platform designed for higher-volume delivery.